BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 9891477)

  • 1. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M
    Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
    Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
    Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
    Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
    Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
    J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
    Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
    J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of interleukin-5 production by CD4- CD8- (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canis.
    Takamoto M; Kusama Y; Takatsu K; Nariuchi H; Sugane K
    Immunology; 1995 Jun; 85(2):285-91. PubMed ID: 7642218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; PĂ©ron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
    Tsung K; Dolan JP; Tsung YL; Norton JA
    Cancer Res; 2002 Sep; 62(17):5069-75. PubMed ID: 12208763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR; Renauld JC; Houssiau FA
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration.
    Hara I; Nagai H; Miyake H; Yamanaka K; Hara S; Micallef MJ; Kurimoto M; Gohji K; Arakawa S; Ichihashi M; Kamidono S
    Cancer Gene Ther; 2000 Jan; 7(1):83-90. PubMed ID: 10678360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
    BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.
    Ding L; Shevach EM
    J Immunol; 1992 May; 148(10):3133-9. PubMed ID: 1578140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; AntĂșnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.